2m 2m 2m 2m 2m 2m 2m
Annovis Bio (ANVS)
NYSE
$1.82-$0.04 (-2.10%)
Price as of Jun 03, 2026 7:47 PM EDT- $81.7MMarket Cap
- -28.74%1-Year Change
- BiotechnologyIndustry
Annovis Bio (ANVS)
$1.82-$0.04 (-2.10%)
ANVS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.86 | ||
Change | +$0.04 (+2.20%) | ||
Open | $1.94 | ||
High | $1.94 | ||
Low | $1.78 | ||
Previous Close | $1.82 | ||
Volume | 1,519,541 | ||
30-Day Average Volume | 1,312,464 | ||
1-Week Change | -9.71% | ||
1-Month Change | -7.00% | ||
1-Year Change | -28.74% | ||
3-Year Change | -85.96% | ||
5-Year Change | -96.62% | ||
Fundamentals | |||
Shares Outstanding | 42.5M | ||
Total Assets | $16.2M | ||
Market Cap | $81.7M | ||
Enterprise Value | $67.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.6M | ||
Free Cash Flow | -$9.0M | ||
EBIT | -$17.6M | ||
EBITDA | -$17.6M | ||
Net Working Capital | $1.4M | ||
EPS | -$0.63 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 26 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue